This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Cameron Durrant
Chairman and CEO at Humanigen, Inc.


He has been involved in company exits ranging from 2-9x while either CEO or a board member. He has launched 20 brands, including five which sold >$1Bn annually, one which generated >$3Bn annually and two of the six fastest selling blockbusters in pharma history and 3 brands nominated for Prix Galien awards. Dr. Durrant is familiar with all stages of drug development, registration and commercialization and has raised money in diverse and difficult circumstances. He is an experienced public and private company board member, having held prior roles of Chairman, Executive Chairman, Chair of Audit Committee, Chair of Compensation Committee, member of Nominating Committee, member of Transactions Committee for several public and private biotech and medical device company boards and is well-versed in SEC and NASDAQ/NYSE securities requirements, Delaware public company law and board governance good practices.

Agenda Sessions

  • Efficacy/Toxicity Linkage with CAR and T Cell Therapies